Substituted oxadiazoles: a patent review (2010 - 2012)
- PMID: 23663160
- DOI: 10.1517/13543776.2013.797409
Substituted oxadiazoles: a patent review (2010 - 2012)
Abstract
Introduction: The oxadiazoles represent a class of five-membered heterocyclic compounds which are of considerable interest in different areas of medicinal chemistry and drug discovery. Oxadiazoles can exist in different regioisomeric forms and employ in various agents with a broad range of biological activities. This review covers the work reported on various biological activities of oxadiazole derivatives from 2010 to 2012.
Areas covered: Oxadiazole derivatives attract great attention due to their different kinds of pharmaceutical activities including antiviral, antimicrobial, anticancer, anticonvulsant, antidiabetic and anti-inflammatory activity. This paper provides a general review of oxadiazole derivatives published in international journals and patented between 2010 and 2012.
Expert opinion: Oxadiazoles have been used frequently in drug-like molecules as bioisosteres for ester and amide functionalities and displayed numerous prominent pharmacological effects. The broad pharmacological profile of oxadiazole derivatives has attracted the attention of many researchers to explore this scaffold to its multiple potential against several activities. Therefore, oxadiazole motif is likely to be present in other therapeutic molecules in the future.
Similar articles
-
Pyrazine derivatives: a patent review (2008 - present).Expert Opin Ther Pat. 2012 Sep;22(9):1033-51. doi: 10.1517/13543776.2012.714370. Epub 2012 Aug 6. Expert Opin Ther Pat. 2012. PMID: 22860922 Review.
-
1,3,4-oxadiazole: a biologically active scaffold.Mini Rev Med Chem. 2012 Jul;12(8):789-801. doi: 10.2174/138955712801264800. Mini Rev Med Chem. 2012. PMID: 22512560 Review.
-
A Review Exploring Therapeutic Worth of 1,3,4-Oxadiazole Tailored Compounds.Mini Rev Med Chem. 2019;19(6):477-509. doi: 10.2174/1389557518666181015152433. Mini Rev Med Chem. 2019. PMID: 30324877 Review.
-
A patent review of pharmaceutical and therapeutic applications of oxadiazole derivatives for the treatment of chronic diseases (2013-2021).Expert Opin Ther Pat. 2022 Sep;32(9):969-1001. doi: 10.1080/13543776.2022.2116312. Epub 2022 Sep 6. Expert Opin Ther Pat. 2022. PMID: 35993146 Review.
-
Oxadiazole: A highly versatile scaffold in drug discovery.Arch Pharm (Weinheim). 2022 Sep;355(9):e2200123. doi: 10.1002/ardp.202200123. Epub 2022 May 16. Arch Pharm (Weinheim). 2022. PMID: 35575467 Review.
Cited by
-
Synergism of a Novel 1,2,4-oxadiazole-containing Derivative with Oxacillin against Methicillin-Resistant Staphylococcus aureus.Antibiotics (Basel). 2021 Oct 16;10(10):1258. doi: 10.3390/antibiotics10101258. Antibiotics (Basel). 2021. PMID: 34680838 Free PMC article.
-
Progress in HIV-1 Integrase Inhibitors: A Review of their Chemical Structure Diversity.Iran J Pharm Res. 2016 Fall;15(4):595-628. Iran J Pharm Res. 2016. PMID: 28243261 Free PMC article. Review.
-
Current Research on Antiepileptic Compounds.Molecules. 2015 Nov 20;20(11):20741-76. doi: 10.3390/molecules201119714. Molecules. 2015. PMID: 26610448 Free PMC article. Review.
-
Synthesis, biological evaluation and docking studies of 1,2,4-oxadiazole linked 5-fluorouracil derivatives as anticancer agents.BMC Chem. 2021 May 4;15(1):30. doi: 10.1186/s13065-021-00757-y. BMC Chem. 2021. PMID: 33947440 Free PMC article.
-
Design, Synthesis, Molecular Modeling, In Silico ADME Studies and Anti-HIV-1 Assay of New Diazocoumarin Derivatives.Iran J Pharm Res. 2018;17(Suppl2):65-77. Iran J Pharm Res. 2018. PMID: 31011343 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
